Azotemia - 25 Studies Found
Terminated |
: Complement Inhibition in aHUS Dialysis Patients : Atypical Hemolytic Uremic Syndrome : 2015-05-26 : Drug: CCX168 |
Completed |
: A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS) : Atypical Hemolytic Uremic Syndrome (aHUS) : 2012-11-13 |
Completed |
: The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS) : Atypical Hemolytic Uremic Syndrome (aHUS) : 2012-12-04 : Drug: Eculizumab |
Completed |
: To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients : ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) : 2012-12-04 |
Recruiting |
: Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry : Atypical Hemolytic-Uremic Syndrome : 2012-01-18 |
Terminated |
: aHUS Observational Long Term Follow-Up : Atypical Hemolytic Uremic Syndrome : 2012-01-18 |
Completed |
: An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome : Atypical Hemolytic-Uremic Syndrome : 2010-08-31 : Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
: An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome : Atypical Hemolytic-Uremic Syndrome : 2010-08-31 : Drug: Eculizumab Fixed dosing is based on body weight cohorts. Adjustment of dose to accommodate patient |
Completed |
: Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS : Atypical Hemolytic Uremic Syndrome : 2009-02-13 : Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
: Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS : Atypical Hemolytic Uremic Syndrome : 2009-02-13 : Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |